^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MGD007

    i
    Other names: MGD007 , MGD 007, MGD-007, CD3 x gpA33 DART molecule
    Associations

    News

    Trials
    Company:
    MacroGenics
    Drug class:
    CD3 inhibitor, Glycoprotein A33 inhibitor
    Related drugs:
    Associations

    News

    Trials
    3years
    MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer (clinicaltrials.gov)
    P1b/2, N=38, Completed, MacroGenics | Active, not recruiting --> Completed
    Clinical • Trial completion • Combination therapy
    |
    PD-L1 (Programmed death ligand 1) • PD-1 (Programmed cell death 1)
    |
    PD-L1 expression
    |
    Zynyz (retifanlimab-dlwr) • MGD007